C
Camil Castelo-Branco
Researcher at University of Barcelona
Publications - 263
Citations - 6758
Camil Castelo-Branco is an academic researcher from University of Barcelona. The author has contributed to research in topics: Menopause & Osteoporosis. The author has an hindex of 40, co-authored 240 publications receiving 5932 citations. Previous affiliations of Camil Castelo-Branco include University of Alcalá & University of Granada.
Papers
More filters
Journal ArticleDOI
Understanding weight gain at menopause
Susan R. Davis,Camil Castelo-Branco,Peter Chedraui,Mary Ann Lumsden,Rossella E. Nappi,D. Shah,P. Villaseca +6 more
TL;DR: There is strong evidence that estrogen therapy may partly prevent this menopause-related change in body composition and the associated metabolic sequelae and further studies are required to identify the women most likely to gain metabolic benefit from menopausal hormone therapy in order to develop evidence-based clinical recommendations.
Journal ArticleDOI
The immune system and aging: a review.
Camil Castelo-Branco,I. Soveral +1 more
TL;DR: In this review, an attempt is made to summarize the current knowledge on how the immune system is affected by the aging process.
Journal ArticleDOI
Quality of life after the menopause: a population study
Juan E. Blümel,Camil Castelo-Branco,Lorena Binfa,G. Gramegna,X. Tacla,B. Aracena,M.A. Cumsille,A. Sanjuán +7 more
TL;DR: Menopause causes a decrease in quality of life, which is independent from age and other sociodemographic variables, and logistic regression demonstrated that the only variable found to cause a significant impairment in QoL was menopause.
Journal ArticleDOI
Management of post-menopausal vaginal atrophy and atrophic vaginitis.
TL;DR: This review focuses on the changes involved in vaginal aging and efforts to present a synopsis of the pathophysiology and therapy of atrophic vaginitis and vaginal atrophy.
Journal ArticleDOI
Tolerability of different oral iron supplements: a systematic review
Maria Jesús Cancelo-Hidalgo,Camil Castelo-Branco,Santiago Palacios,Javier Haya-Palazuelos,Manel Ciria-Recasens,José Manasanch,L. Pérez-Edo +6 more
TL;DR: Extended-release ferrous sulfate with mucoproteose appears to be the best tolerated of the different oral iron supplements evaluated and is considered a strength in tolerability studies.